Kwality Pharmaceuticals Ltd receives approval from INVIMA for Ampoule and Vial product lines

Kwality Pharmaceuticals Ltd has received the approval (inspection from 15 April to 19th April, 2024) from the Columbian Drug Regulatory Authority - INVIMA (INVIMA is the National Institute for the surveillance of Drugs and Food designated by the Columbian Ministry of the Social Protection) for Amritsar unit-1 block W1 for below mentioned categories having capacity of 100,000 Vials &100,000Amp.per day:

Small Volume Parentals - Liquid solutions - Ampoule

Small Volume Parentals - Liquid solutions, emulsions and Lyphollized for injections - Vial

Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies. Presently we are exporting against permit of permitted quantity. This will open new market for us. The registered products of Colombia are saleable in Argentina, Dominican Republic, Costa Rica, Ecuador, E] Salvador, Guatemala, Mexico, Panama, Paraguay, Peru, Uruguay, Bouivia, Cuba, Chile, Honduras, Nicaragua. This will give an opportunity to register and sell about 10 niche products and 100 general products. The success is reinforcing our commitment to high regulatory standards and expected to aid revenue growth in the coming quarters through this approval.

Shares of Kwality Pharmaceuticals Ltd was last trading in BSE at Rs. 470.95 as compared to the previous close of Rs. 448.55. The total number of shares traded during the day was 7778 in over 98 trades.

The stock hit an intraday high of Rs. 470.95 and intraday low of 448.00. The net turnover during the day was Rs. 3616207.00.

Source : Equity Bulls

Keywords

KwalityPharmaceuticals INE552U01010 Approval INVIMA Ampoule Vial ProductLines